adenosine monophosphate has been researched along with Chronic Kidney Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 5 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, EM; Berceli, SA; Cort, TA; Fazzone, B; Harland, KC; Hu, Q; Khattri, RB; Kim, K; O'Malley, KA; Palzkill, VR; Ryan, TE; Scali, ST | 1 |
| Emanuela, C; Francesco, L; Giorgia, G; Pasquale, N; Roberto, P; Sara, D | 1 |
| Bruchfeld, A | 1 |
| Govil, A; Luckett, K; Miller-Handley, H | 1 |
| Klussmann, E; Sholokh, A | 1 |
| Ando, F; Arai, Y; Furusho, T; Isobe, K; Kikuchi, H; Maejima, Y; Mandai, S; Minamishima, YA; Mori, T; Nomura, N; Okado, T; Rai, T; Sasaki, E; Sohara, E; Takahashi, N; Uchida, S; Yamashita, T; Yoshizaki, Y | 1 |
4 review(s) available for adenosine monophosphate and Chronic Kidney Diseases
| Article | Year |
|---|---|
Current treatment of COVID-19 in renal patients: hope or hype?
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal; Cobicistat; Coronavirus Infections; COVID-19; Darunavir; Drug Combinations; Humans; Kidney; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Renal Insufficiency, Chronic; Renal Replacement Therapy; Ritonavir | 2020 |
The COVID-19 pandemic: consequences for nephrology.
Topics: Acute Kidney Injury; Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Glucocorticoids; Humans; Kidney Failure, Chronic; Kidney Transplantation; Nephrology; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; SARS-CoV-2; Severity of Illness Index | 2021 |
Treatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function.
Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Creatinine; Cytidine; Dexamethasone; Drug Combinations; Drug Interactions; Humans; Hydroxychloroquine; Hydroxylamines; Immunization, Passive; Interferons; Janus Kinase Inhibitors; Lopinavir; Pyrazines; Renal Elimination; Renal Insufficiency, Chronic; Renal Replacement Therapy; Ribavirin; Ritonavir; SARS-CoV-2 | 2020 |
Local cyclic adenosine monophosphate signalling cascades-Roles and targets in chronic kidney disease.
Topics: Adenosine Monophosphate; Aquaporin 2; Cyclic AMP; Humans; Renal Insufficiency, Chronic; Signal Transduction; Ubiquitin-Protein Ligases | 2021 |
2 other study(ies) available for adenosine monophosphate and Chronic Kidney Diseases
| Article | Year |
|---|---|
Metabolomic profiling reveals muscle metabolic changes following iliac arteriovenous fistula creation in mice.
Topics: Adenine; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Arteriovenous Fistula; Arteriovenous Shunt, Surgical; Creatine; Kidney Failure, Chronic; Mice; Muscles; Renal Dialysis; Renal Insufficiency, Chronic | 2022 |
Failure to sense energy depletion may be a novel therapeutic target in chronic kidney disease.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Biphenyl Compounds; Diet, Protein-Restricted; Disease Models, Animal; Energy Metabolism; Fibrosis; Humans; Kidney; Male; Metabolomics; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Myocardium; Pyrones; Renal Insufficiency, Chronic; Signal Transduction; Thiophenes | 2019 |